Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital. by Kimberly Saddler, Jason Zhang, Jennifer Sul, Pruthvi Patel, Miriams Castro-Lainez, Mark L Stevens, Sheryl Kosler, Emily Lowery, Miguel Sierra-Hoffman

Get full text

Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studies by Fernando Valerio-Pascua, Fernando Baires, Anupamjeet Kaur Sekhon, Mari L. Tesch, Estela Jackeline Pineda, Syed A. A. Rizvi, Jarmanjeet Singh, David Abraham Cortes-Bandy, Amy C. Madril, Jana Radwanski, Anita S. Lewis, Miguel Sierra-Hoffman, Mark L. Stevens, Franck F. Rahaghi

Get full text

Novel approaches in the treatment of Hansen’s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States by Carlos Franco-Paredes, Elizabeth Garcia-Creighton, Andrés Henao-Martínez, Diane L. Kallgren, Rashmi Banjade, Jon A. Dyer, Taylor Nelson, Araya Zaesim, Michael J. Peluso, Vivek Jain, Dong Heun Lee, Lucio R. Minces, Mary Wirshup, Miguel Sierra Hoffman, Jenn Katsolis, Karen Brust, Jose Giron, Lauren Smiarowski, Pauline A. Hoosepian-Mer, Barbara Stryjewska

Get full text

Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study by Estela Pineda, Jarmanjeet Singh, Miguel Vargas Pineda, Jose Garay Umanzor, Fernando Baires, Luis G. Benitez, Cesar Burgos, Anupamjeet Kaur Sekhon, Nicole Crisp, Anita S. Lewis, Jana Radwanski, Marco Bermudez, Karen Sanchez Barjun, Oscar Diaz, Elsa Palou, Rossany E. Escalante, Carlos Isai Hernandez, Mark L. Stevens, Deke Eberhard, Manuel Sierra, Tito Alvarado, Omar Videa, Miguel Sierra-Hoffman, Fernando Valerio-Pascua

Get full text